Skip to main content
. 2013 Oct 11;105(21):1656–1666. doi: 10.1093/jnci/djt279

Figure 3.

Figure 3.

Cumulative incidences of non-cancer mortality by type of radiotherapy treatment and risk group. Gray’s test P values are for overall, pelvic radiotherapy vs no radiotherapy, and vaginal brachytherapy alone vs no radiotherapy, respectively. A ) Low-risk, stage I ( P < .01, P < .05, P < .05). B ) Intermediate-risk, stage I ( P < .001, P < .001, P < .001). C ) High-risk, stage I ( P < .001, P < .001, P < .01). D ) Stage IIA (1988 Fédération Internationale de Gynécologie Obstétrique staging system)/stage II not otherwise specified ( P < .001, P < .001, P < .01). E ) Stage II ( P < .001, P < .001, P < .05). RT = radiotherapy; VB = vaginal brachytherapy; WPRT = whole pelvic radiotherapy.